Simplify Logo

Full-Time

Director – Channel Management

Confirmed live in the last 24 hours

Alamar Biosciences

Alamar Biosciences

51-200 employees

Develops technology for protein detection and measurement

Hardware
Biotechnology

Compensation Overview

$160k - $180kAnnually

+ Commission + Equity + Benefits

Expert

Fremont, CA, USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Communications
Marketing
Data Analysis
Requirements
  • Bachelor’s degree in BSc/Commerce/Economics, master’s degree in business administration (preferred) or equivalent work experience
  • 15+ years of demonstrated experience in similar role with a strong focus on sales and channel development in life sciences and medical devices
  • Track record for achieving sales targets, AR collections, and partner recruitment and enablement
  • Ability to work closely with commercial and finance
  • Excellent knowledge and experience working with dealers and distributors in various geographic areas
  • Ability to put a business plan together based on data, analytics, and creative solutions to address opportunities
  • Excellent verbal and written communication skills and ability to interact with technical and business counterparts
Responsibilities
  • Create and drive channel strategy to reach business growth targets globally
  • Build annual plans and performance measures with channel partners
  • Implement scorecard and process for metrics; distribution, collection and ongoing quarterly performance monitoring
  • Structure sales training and marketing programs to drive partner effectiveness
  • Lead channel processes and workflows and maintains a successful business
  • Drive contract development process and negotiations, working with internal functions and external partners
  • Ensure legal and ethical compliance in business interactions

Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company has created NULISA™, a technology that can detect and measure proteins in the human body with high sensitivity and a wide range. This allows researchers and clinicians to profile clinically relevant protein biomarkers, which are essential for developing new diagnostic tests and treatments for various diseases. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics. Unlike many competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it accessible to a broader range of clients. The goal of Alamar Biosciences is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options.

Company Stage

Series C

Total Funding

$224.3M

Headquarters

Hayward, California

Founded

2018

Growth & Insights
Headcount

6 month growth

23%

1 year growth

37%

2 year growth

115%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $128 million Series C financing round positions Alamar for accelerated growth and commercialization of its proteomics platform.
  • The launch of innovative products like the NULISAseq™ CNS Disease Panel 120 and NULISAqpcr™ pTau-217 Assay demonstrates Alamar's commitment to advancing disease research and diagnostics.
  • Collaborations with leading organizations in aging and neurodegenerative disease research could lead to groundbreaking discoveries and new market opportunities.

What critics are saying

  • The highly competitive biotechnology sector requires continuous innovation to maintain a leading position.
  • Dependence on strategic partnerships and collaborations may pose risks if these relationships falter or fail to deliver expected outcomes.

What makes Alamar Biosciences unique

  • Alamar BioSciences' NULISA™ technology offers unprecedented sensitivity and range in protein detection, setting it apart from traditional proteomics solutions.
  • The ARGO™ system's fully automated, high-throughput capabilities reduce the need for technical expertise, making it more accessible to a broader range of clients.
  • Strategic partnerships, such as with the Biomarkers of Aging Consortium and ALZpath, enhance Alamar's credibility and expand its research applications.